Disrupts is a cutting-edge media platform delivering the latest news, insights, and stories that shape the global tech ecosystem.
iHerb Opens Fulfillment Center in Riyadh to Boost MENA Operations
iHerb has launched a new fulfillment center in Riyadh, Saudi Arabia, enhancing delivery speed, local inventory, and service across the Middle East and North Africa. The 40,000 sqm, climate-controlled facility strengthens the company’s regional e-commerce and logistics capabilities.
Dubai SME Partners with Al Tadawi Healthcare to Boost Emirati-Owned SMEs
Dubai SME has signed a strategic cooperation agreement with Al Tadawi Healthcare Group to expand procurement access, commercial visibility, and growth opportunities for Emirati-owned SMEs. The partnership offers tailored procurement, discounted commercial spaces, and priority supplier opportunities, supporting the Dubai Economic Agenda (D33) and strengthening the UAE’s SME ecosystem.
Ant Group Upgrades AI Health Assistant AQ with DeepSearch for Clinicians
Ant Group enhances its AI-native health assistant AQ with DeepSearch, offering clinicians rapid access to evidence-based guidelines, structured research, and clinical decision support. The platform integrates 36M+ publications and supports high-quality, reliable medical recommendations across China.
Multiply Labs Brings Robotics and AI to Scale Cell Therapy Manufacturing
Multiply Labs is revolutionizing cell therapy production with robotic systems and AI-driven digital twins, cutting costs by up to 70%, increasing throughput, and reducing contamination risk, making life-saving therapies more scalable and accessible.
Harley-Davidson Dubai Raises Men’s Health Awareness Across GCC
For Men’s Health Month, Dubai’s Harley-Davidson Chapter goes viral with a humorous, heartfelt campaign promoting early screening for prostate and testicular cancer, engaging men across the GCC and sparking vital conversations on male health.
NVIDIA and Eli Lilly Launch AI Co-Innovation Lab to Accelerate Drug Discovery
A strategic collaboration worth up to $1 billion unites NVIDIA and Eli Lilly to harness AI for drug development, speeding up discovery and research with advanced biomedical models.